Anaesthesia Management and Use of Sugammadex in a Patient with Ullrich's Disease

---

Atıf İçin Kopyala

Erbabacan E., Koksal G. M., Seker T. B., Ekici B., Ozcan R., Altindas F.

TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, cilt.43, sa.5, ss.356-359, 2015 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 43 Sayı: 5
• Basım Tarihi: 2015
• Doi Numarası: 10.5152/tjar.2015.22448
• Dergi Adı: TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
• Sayfa Sayıları: ss.356-359
• İstanbul Üniversitesi Adresli: Evet

Özet

Here, we report anaesthesia management and the successful use of total intravenous anaesthesia and sugammadex in a patient with Ullrich's disease. Propofol and remifentanyl infusion was used for anaesthesia. After the end of the surgery, when the train-of-four value was 0%, 4 mg kg(-1) sugammadex was administered, and the patient was successfully extubated after 36 s. No adverse effects or safety concerns were observed. In conclusion, we suggest that the use of propofol infusion to avoid the use of inhalation anaesthetics and the use of sugammadex for the reversal of the effects of rocuronium is safe in patients with Ullrich's disease.